Literature DB >> 23523099

Risk of stillbirth after 37 weeks in pregnancies complicated by small-for-gestational-age fetuses.

Amanda S Trudell1, Alison G Cahill, Methodius G Tuuli, George A Macones, Anthony O Odibo.   

Abstract

OBJECTIVE: The evidence for delivering small-for-gestational-age (SGA) fetuses at 37 weeks remains conflicting. We examined the risk of stillbirth per week of gestation beyond 37 weeks for pregnancies complicated by SGA. STUDY
DESIGN: Singleton pregnancies undergoing routine second trimester ultrasound from 1990-2009 were examined retrospectively. The risk of stillbirth per 10,000 ongoing SGA pregnancies with 95% confidence intervals (CIs) was calculated for each week of gestation ≥37 weeks. Using a life-table analysis with correction for censoring, conditional risks of stillbirth, cumulative risks of stillbirth per 10,000 ongoing SGA pregnancies and relative risks (RRs) were calculated with 95% CIs for each week of gestation.
RESULTS: Among 57,195 pregnancies meeting inclusion criteria the background risk of stillbirth was 56/10,000 (95% CI, 42.3-72.7) with stillbirth risk for SGA pregnancies of 251/10,000 (95% CI, 221.2-284.5). The risk of stillbirth after the 37th week was greater compared with pregnancies delivered in the 37th week (47/10,000, 95% CI, 34.6-62.5 vs 21/10,000, 95% CI, 13.0-32.1; RR, 2.2; 95% CI, 1.3-3.7). The cumulative risk of stillbirth rose from 28/10,000 ongoing SGA pregnancies at 37 weeks to 77/10,000 at 39 weeks (RR, 2.75; 95% CI, 1.79-4.2). Among pregnancies complicated by SGA <5% the cumulative risk of stillbirth at 38 weeks was significantly greater than the risk at 37 weeks (RR, 2.3; 95% CI, 1.4-3.8).
CONCLUSION: There is a significantly increased risk of stillbirth in pregnancies complicated by SGA delivered after the 37th week. Given these findings, we advocate a policy of delivery of SGA pregnancies 37-38 weeks.
Copyright © 2013 Mosby, Inc. All rights reserved.

Mesh:

Year:  2013        PMID: 23523099     DOI: 10.1016/j.ajog.2013.02.030

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

Review 1.  Stillbirth in the pregnancy complicated by diabetes.

Authors:  Roman Starikov; Donald Dudley; Uma M Reddy
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

2.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

3.  Maternal erythrocyte ENT1-mediated AMPK activation counteracts placental hypoxia and supports fetal growth.

Authors:  Seisuke Sayama; Anren Song; Benjamin C Brown; Jacob Couturier; Xiaoli Cai; Ping Xu; Changhan Chen; Yangxi Zheng; Takayuki Iriyama; Baha Sibai; Monica Longo; Rodney E Kellems; Angelo D'Alessandro; Yang Xia
Journal:  JCI Insight       Date:  2020-05-21

4.  Prediction of adverse perinatal outcome by fetal biometry: comparison of customized and population-based standards.

Authors:  D Kabiri; R Romero; D W Gudicha; E Hernandez-Andrade; P Pacora; N Benshalom-Tirosh; D Tirosh; L Yeo; O Erez; S S Hassan; A L Tarca
Journal:  Ultrasound Obstet Gynecol       Date:  2020-02       Impact factor: 7.299

Review 5.  Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach.

Authors:  Christoph C Lees; Roberto Romero; Tamara Stampalija; Andrea Dall'Asta; Greggory A DeVore; Federico Prefumo; Tiziana Frusca; Gerard H A Visser; John C Hobbins; Ahmet A Baschat; Caterina M Bilardo; Henry L Galan; Stuart Campbell; Dev Maulik; Francesc Figueras; Wesley Lee; Julia Unterscheider; Herbert Valensise; Fabricio Da Silva Costa; Laurent J Salomon; Liona C Poon; Enrico Ferrazzi; Giancarlo Mari; Giuseppe Rizzo; John C Kingdom; Torvid Kiserud; Kurt Hecher
Journal:  Am J Obstet Gynecol       Date:  2022-01-10       Impact factor: 10.693

6.  Balancing the risks of stillbirth and neonatal death in the early preterm small-for-gestational-age fetus.

Authors:  Amanda S Trudell; Methodius G Tuuli; Alison G Cahill; George A Macones; Anthony O Odibo
Journal:  Am J Obstet Gynecol       Date:  2014-04-15       Impact factor: 8.661

7.  The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy E Whitten; Steven J Korzeniewski; Piya Chaemsaithong; Edgar Hernandez-Andrade; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2016

8.  The growth-restricted fetus: risk of mortality by each additional week of expectant management.

Authors:  Rachel A Pilliod; Jessica M Page; Teresa N Sparks; Aaron B Caughey
Journal:  J Matern Fetal Neonatal Med       Date:  2017-10-03

9.  Uncomplicated Pregnancies and Ultrasounds for Fetal Growth Restriction: A Pilot Randomized Clinical Trial.

Authors:  Ibrahim A Hammad; Suneet P Chauhan; Malgorzata Mlynarczyk; Nader Rabie; Chris Goodie; Eugene Chang; Everett F Magann; Alfred Z Abuhamad
Journal:  AJP Rep       Date:  2015-11-16

10.  Timing and cause of perinatal mortality for small-for-gestational-age babies in South Africa: critical periods and challenges with detection.

Authors:  Tina Lavin; David B Preen; Robert Pattinson
Journal:  Matern Health Neonatol Perinatol       Date:  2016-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.